GlucoTrack (NASDAQ:GCTK – Get Free Report) and Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.
Earnings & Valuation
This table compares GlucoTrack and Kewaunee Scientific”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| GlucoTrack | N/A | N/A | -$19.39 million | ($18.04) | -0.02 |
| Kewaunee Scientific | $282.00 million | 0.37 | $9.62 million | $3.22 | 11.25 |
Volatility & Risk
GlucoTrack has a beta of 0.7, meaning that its stock price is 30% less volatile than the S&P 500. Comparatively, Kewaunee Scientific has a beta of 0.72, meaning that its stock price is 28% less volatile than the S&P 500.
Insider and Institutional Ownership
10.9% of GlucoTrack shares are held by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are held by institutional investors. 8.4% of GlucoTrack shares are held by insiders. Comparatively, 14.1% of Kewaunee Scientific shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares GlucoTrack and Kewaunee Scientific’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| GlucoTrack | N/A | -581.98% | -220.10% |
| Kewaunee Scientific | 3.41% | 14.10% | 5.55% |
Analyst Ratings
This is a summary of current ratings and price targets for GlucoTrack and Kewaunee Scientific, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| GlucoTrack | 1 | 0 | 0 | 0 | 1.00 |
| Kewaunee Scientific | 0 | 1 | 0 | 0 | 2.00 |
Summary
Kewaunee Scientific beats GlucoTrack on 11 of the 11 factors compared between the two stocks.
About GlucoTrack
GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
About Kewaunee Scientific
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.
Receive News & Ratings for GlucoTrack Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlucoTrack and related companies with MarketBeat.com's FREE daily email newsletter.
